Role of duration of diuretic effect in preventing sodium retention

[1]  F. Russel,et al.  Diuretic efficacy of high dose furosemide in severe heart failure: bolus injection versus continuous infusion. , 1996, Journal of the American College of Cardiology.

[2]  Johan Gabrielsson,et al.  Pharmacodynamic modeling of furosemide tolerance after multiple intravenous administration , 1996, Clinical pharmacology and therapeutics.

[3]  D. Brater,et al.  Pharmacodynamics of Torsemide Administered as an Intravenous Injection and as a Continuous Infusion to Patients with Congestive Heart Failure , 1996, Journal of clinical pharmacology.

[4]  D. Brater,et al.  Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide and furosemide in patients with congestive heart failure , 1995, Clinical pharmacology and therapeutics.

[5]  G. Matzke,et al.  The pharmacokinetics of intravenous and oral torsemide in patients with chronic renal insufficiency , 1994, Clinical pharmacology and therapeutics.

[6]  D. Brater,et al.  The pharmacodynamics of torsemide in patients with congestive heart failure , 1994, Clinical pharmacology and therapeutics.

[7]  G. Alván,et al.  The In Vivo Study of Drug Action , 1994 .

[8]  F. Russel,et al.  Continuous infusion of furosemide in the treatment of patients with congestive heart failure and diuretic resistance , 1994, Journal of internal medicine.

[9]  D. Pound,et al.  Bioavailability, pharmacokinetics, and pharmacodynamics of torsemide in patients with cirrhosis , 1993, Clinical pharmacology and therapeutics.

[10]  C. Wilcox,et al.  A volume-independent component to postdiuretic sodium retention in humans. , 1993, Journal of the American Society of Nephrology : JASN.

[11]  M. Lahav,et al.  Intermittent administration of furosemide vs continuous infusion preceded by a loading dose for congestive heart failure. , 1992, Chest.

[12]  F. Russel,et al.  Diuretic efficiency of furosemide during continuous administration versus bolus injection in healthy volunteers , 1992, Clinical pharmacology and therapeutics.

[13]  D. Brater,et al.  Loop diuretics for chronic renal insufficiency: a continuous infusion is more efficacious than bolus therapy. , 1991, Annals of internal medicine.

[14]  T. Villén,et al.  Diuretic effect and diuretic efficiency after intravenous dosage of frusemide. , 1990, British journal of clinical pharmacology.

[15]  D. Brater,et al.  Clinical pharmacology of torasemide, a new loop diuretic , 1987, Clinical pharmacology and therapeutics.

[16]  J. Mackenzie,et al.  Postoperative enhancement of urinary output in patients with acute renal failure using continuous furosemide therapy. , 1986, Chest.

[17]  L. Paalzow,et al.  Acute tolerance to furosemide diuresis in humans. Pharmacokinetic-pharmacodynamic modeling. , 1985, The Journal of pharmacology and experimental therapeutics.

[18]  J. Copeland,et al.  Diuresis with continuous infusion of furosemide after cardiac surgery. , 1983, American journal of surgery.

[19]  P. A. Friedman,et al.  Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. , 1983, The Journal of laboratory and clinical medicine.

[20]  D. Brater,et al.  Bumetanide and furosemide , 1983, Clinical pharmacology and therapeutics.

[21]  B. Beermann,et al.  Clinical Pharmacokinetics of Diuretics , 1980, Clinical pharmacokinetics.

[22]  D. Brater.  Diuretic Pharmacokinetics and Pharmacodynamics , 1997 .